“Synthetic Silicon-Incorporated Cannabinoids Inhibit Heme-Induced NLRP3 Inflammasome: Potential for Inflammatory Diseases Treatment”

https://pubmed.ncbi.nlm.nih.gov/38116428

Synthetic silicon-incorporated cannabinoids show promising inhibition of heme-induced NLRP3 inflammasome, offering potential for treatment of inflammatory diseases like sickle cell anemia and thalassemia.